en

PRODUCT DETAIL

Ondansetron Kabi 0,08 mg/ml

Code 1425E
MA number 20/0185/22-S
Product Form: sol inf 1x100 ml/8 mg (fľ.LDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 20 - ANTIEMETICA, ANTIVERTIGINOSA
ATC:
A ALIMENTARY TRACT AND METABOLISM
A04 ANTIEMETICS
A04A ANTIEMETICS AND ANTINAUSEANTS
A04AA Serotonin (5HT3) antagonists
A04AA01 Ondansetron
Shelf life: 30
Container: bottle LDPE
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 01.07.2022
Validity: 01.07.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Ondansetron Kabi 0,08 mg_ml; 0,16 mg_ml_07 2022.pdf  
SPC: SPC_Ondansetron Kabi 0,08 mg_ml; 0,16 mg_ml_07 2022.pdf  
Safety feature Yes
Data update: 11.07.2022
eu-flag.png sk-flag.png